PRS27 Cost-Utility Analysis of Omalizumab Compared with Standard Therapy in Patients Over Twelve Years Old with Severe Asthma from the Colombian Health System Perspective
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.311
https://www.valueinhealthjournal.com/article/S1098-3015(12)00376-2/fulltext
Title :
PRS27 Cost-Utility Analysis of Omalizumab Compared with Standard Therapy in Patients Over Twelve Years Old with Severe Asthma from the Colombian Health System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00376-2&doi=10.1016/j.jval.2012.03.311
First page :
A56
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1090